Key Stats for Axon Stock
- Current Price: $433.04
- Target Price (Mid): ~$1,185
- Street Target: ~$662
- Potential Total Return: ~174%
- Annualized IRR: ~25% / year
- Earnings Reaction: +10.63% (5/6/26)
Now Live: Discover how much upside your favorite stocks could have using TIKR’s new Valuation Model (It’s free) >>>
What Happened?
Axon Enterprise (AXON) has spent most of 2026 testing the patience of its own believers. The stock sits at $433.04 after a 5.61% jump on June 23, yet it remains far below its 52-week high of $885.92. The business never stumbled. The multiple did. That gap is the tension every Axon investor is trying to resolve.
Most of the recent debate has been fixated on valuation. The sharper insight came from a single investor event. Speaking at the 46th Annual William Blair Growth Stock Conference on June 4, Axon President Josh Isner reframed how to think about the company’s newest growth engine. Discussing Dedrone, the counter-drone platform Axon bought in late 2024, Isner said, “We’ve already booked more dollars on that product than we paid for the acquisition.” In under two years, a tuck-in deal has already booked more than its purchase price. The drone story is not a someday option. It is converting into bookings now.
Why the drone platform changes the Axon thesis
For years, Axon was the TASER company, then the body camera company, then the cloud evidence company. Counter-drone is the next layer, and it is scaling faster than the lines before it. Isner said at the conference that Dedrone was up around 300% year over year in Q1 2026, making it one of the fastest-growing product lines in the portfolio. He called Axon’s new markets a place where “the game hasn’t even started yet.”
The timing is not an accident. Drone warfare has become central to conflicts in Ukraine and the Middle East, and that visibility pulled demand forward. Isner pointed directly at the relevance “in what’s going on in Ukraine and Iran right now.” Counter-drone technology, meaning systems that detect, track, and eventually disable unauthorized drones, has moved from a niche defense concept to a public safety priority.
A fresh partnership reinforces the build-out. On May 27, Axon announced it would integrate radar from Echodyne into its Axon Air and Dedrone platforms. The companies said the combined system already manages hundreds of Drone as First Responder operations daily, with dozens more deployments underway. Eric Hertz, Executive Vice President of Operations at Axon, said agencies “need trusted technologies that help them operate safely and confidently in increasingly complex airspace environments.” For a platform business, every new sensor that feeds the network deepens the moat.
The wedge into every U.S. city
The most overlooked detail from the conference was regulatory. Today, the power to physically take a drone out of the sky sits with the FAA, not local police. That has kept state and local agencies, normally Axon’s fastest adopters, on the sidelines for counter-drone mitigation. The 2026 World Cup is changing that. Isner explained that host cities “are the first cities that have been granted a waiver to be able to mitigate drones.” Cities pay for trailer-mounted units to protect stadium airspace, then remount them on fixed sites across the city, each covering a 2-to-5-kilometer radius. That is the wedge into recurring municipal demand, one city at a time.
See historical and forward estimates for Axon stock (It’s free!) >>>
The numbers behind the bookings story
The drone momentum sits on a business that keeps compounding. Axon reported Q1 2026 revenue of $807.35 million with adjusted EBITDA of $201.63 million, and the stock jumped 10.63% on May 6 in response. Management then raised full-year revenue growth guidance to 30% to 32%, up from 27% to 30%. It was the latest in a run of quarters growing above 30%.
The optimism comes with a real debate. Even after a steep drawdown, Axon trades at an NTM EV/EBITDA near 36x and a forward P/E around 52x, premium multiples that demand flawless execution. Its defense peers highlight the gap: General Dynamics trades near 15x EV/EBITDA and RTX near 18x, against a peer-group median around 18x. Axon carries roughly double the group’s multiple. That premium is defensible given a business still compounding revenue above 30%, but it leaves no room for a miss. Tariff pressure on gross margin and a heavier hardware mix are the near-term risks to watch.
Wall Street still backs the stock. Across 18 analysts, the breakdown is 10 Buys, 8 Outperforms, and 2 Holds, with no Underperform or Sell ratings and a mean target of around $662. Isner addressed the profitability question head-on: “If guns to our head, we had to choose, we’ll take the growth,” he said, arguing profitability is the easier problem once a company is growing 30% a year.
See how Axon performs against its peers in TIKR (It’s free!) >>>
TIKR Advanced Model Analysis
- Current Price: $433.04
- Target Price (Mid): ~$1,185
- Potential Total Return: ~174%
- Annualized IRR: ~25% / year
See analysts’ growth forecasts and price targets for Axon stock (It’s free!) >>>
The target rests on two revenue CAGR engines: high-margin software and AI products sold into existing law enforcement customers, and the new-market push across international, federal, and counter-drone, where Dedrone and the Echodyne radar build-out are accelerating. The margin driver is the mix shift toward recurring software, which lifts net income margin as it scales. The primary risk is multiple compression: at a premium forward multiple, any slip in growth or margins could re-rate the stock lower, regardless of execution.
Upside: the drone and AI flywheels convert backlog into revenue faster than expected, pushing the stock toward the mid-case target.
Downside: tariff-driven margin pressure and a premium multiple collide, capping returns even if revenue keeps growing.
Conclusion
The next proof point is Q2 2026 earnings, expected in early August. Watch counter-drone bookings and the AI Era plan attach rate: another quarter of triple-digit drone bookings growth would confirm the new-market story is real and not event-driven. “Good” looks like revenue growth holding inside the raised 30% to 32% guide while operating margin expands sequentially. “Bad” looks like decelerating bookings or gross margin slipping further on tariffs. Isner says the new markets are still in “the national anthem” before the game starts. August is when investors find out if the team takes the field.
See what stocks billionaire investors are buying so you can follow the smart money with TIKR.
Should You Invest in Axon?
The only way to really know is to look at the numbers yourself. TIKR gives you free access to the same institutional-quality financial data that professional analysts use to answer exactly that question.
Pull up Axon, and you’ll see years of historical financials, what Wall Street analysts expect for revenue and earnings in the quarters ahead, how valuation multiples have moved over time, and whether price targets are trending up or down.
You can build a free watchlist to track Axon alongside every other stock on your radar. No credit card required. Just the data you need to decide for yourself.
Looking for New Opportunities?
- See what stocks billionaire investors are buying so you can follow the smart money.
- Analyze stocks in as little as 5 minutes with TIKR’s all-in-one, easy-to-use platform.
- The more rocks you overturn… the more opportunities you’ll uncover. Search 100K+ global stocks, global top investor holdings, and more with TIKR.
Disclaimer:
Please note that the articles on TIKR are not intended to serve as investment or financial advice from TIKR or our content team, nor are they recommendations to buy or sell any stocks. We create our content based on TIKR Terminal’s investment data and analysts’ estimates. Our analysis might not include recent company news or important updates. TIKR has no position in any stocks mentioned. Thank you for reading, and happy investing!
